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Previously we demonstrated sex differences in episodic memory in healthy elderly and suggested
that normative data be separated by sex. The present study extended the exploration of sex
differences on memory measures into two clinical populations, Mild Cognitive Impairment (MCI)
and Alzheimer's disease (AD). Seventy-six subjects with MCI and 101 subjects with AD
diagnosed by a multidisciplinary team were included. These two groups were also compared to a
group of 177 healthy elderly control participants. Sex differences on the Rey Auditory Verbal
Learning Test (RAVLT) (total and delayed recall) raw scores and Brief Visuospatial Memory TestRevised (BVMT-R) were demonstrated within the healthy but not MCI or AD groups. Calculating
Z-scores by sex for both dementing groups based on the healthy controls suggested a larger
performance gap between healthy and dementing women as compared to healthy and dementing
men. MCI females were on average 0.48 standard deviations lower for total verbal learning
compared to healthy female controls than were MCI males when compared to healthy male
controls. For verbal delayed recall the gap was even larger, 1.09 standard deviations. Similarly, on
the BVMT-R, a measure of visual memory, the difference was 0.60 standard deviations for total
visual learning and 0.99 standard deviations for delayed recall. This same sex difference, with
females showing greater impairment compared to the controls group than did the males, was also
present within the AD group. The greater memory impairment in dementing females rather than
males when compared to sex matched healthy controls was unlikely to be due to more severe
illness since females performed equivalently to males on the Clinical Dementia Rating Scale,
Mini-mental Status Examination, Dementia Rating Scale, and were also similar for age, education,
and apolipoprotein status. The present study suggested relatively greater memory impairment in
females with MCI or AD compared to controls.

Introduction
Previously we demonstrated sex differences on The Rey Auditory Verbal Learning Test
(RAVLT) (Rey, 1964) in 172 healthy elderly (Gale, Baxter, Connor, Herring, & Comer,
2007). The effect size (Cohen, 1992) Cohen's d for females outperforming males was
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“medium” for total number of words recalled over trials 1 through 5 and “large” for free
recall after a twenty minute delay. This effect was not observed on a measure of visuospatial
learning and memory, the Brief Visuospatial Memory Test-Revised (BVMT-R) (Benedict,
1997), although the females' average scores were slightly higher. Given the importance of
detecting subtle memory impairment in clinical situations it was suggested that normative
data for the RAVLT be separated by sex.
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Mild cognitive impairment (MCI) has been described as a translational state that occurs
prior to the clinical diagnosis of Alzheimer's disease (AD) where memory is impaired but
there is often a relative preservation of other cognitive functions, including preservation of
functional status (Petersen et al., 2001; Petersen et al., 1999). Whether MCI is simply very
early AD and not related to a prodromal process will not be debated here, and this paper will
not address the issues related to amnestic MCI versus non-amnestic MCI. However, in a
clinical setting one of the most common questions is whether a patient may or may not be
demonstrating normal age-related changes in memory. While neuropsychological testing
cannot make the definitive diagnosis of dementia, it can be particularly helpful in those cases
where functional status appears intact and the only real complaint, often by family members,
is that of decreased memory. Previous studies have considered a cognitive memory score
that is approximately 1.5 standard deviations (SD) below average, compared to appropriate
controls, as a marker of MCI (Petersen et al., 1999). Given that healthy females in our aging
database outperformed healthy males on delayed recall by approximately 1 SD, on average,
it would be particularly important to compare females to females and males to males in
contrast to some studies that choose not to take sex differences into account (Steinberg,
Bieliauskas, Smith, Ivnik, & Malec, 2005).
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In a study of episodic memory in 84 subjects (42 controls) Chapman et al. (2011) reported
control women outperformed control men, while the opposite was true for subjects
diagnosed with AD. The 21 women with AD scored lower than the 21 men with AD in tests
of both immediate and delayed memory, suggesting that disease progression may affect the
female brain differently than the male brain. This study did not include subjects diagnosed
with MCI so it was unclear if a similar sex difference would be present in earlier stages of
dementia. Similarly, a meta-analysis conducted by Irvine et al. (2012) addressed sex
differences in cognition in subjects diagnosed with AD. They found that cognitive
deterioration appeared to be greater in women than men with AD. While the mechanism for
this finding is unclear, it is possible that there are sex differences in how AD affects the
brain. For example, Skup et al. (2011) found greater loss of gray matter in females with
probable AD and amnestic MCI (aMCI) compared to males with AD and aMCI in a
longitudinal study investigating rates of atrophy. Taken together, we hypothesized that the
sex differences seen on measures of memory in healthy elderly may be absent in dementia,
which if true, may reflect greater cognitive impairment in females than males compared to
healthy elderly. Our aim was to extend our previous findings, and those reported by
Chapman et al. (2011), by analyzing a much larger sample as well as including both a group
of subjects with probable AD and those with MCI. Thus, the current study will extend the
exploration of sex differences in patients with MCI and later stages of AD progression.
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Method
Participants and Procedures
A total of 354 (181 females, 173 males) participants from the Arizona Alzheimer's Disease
Core Center (ADCC) were included in this study. The Arizona ADCC is a consortium that
draws participants from the following sites in Arizona: Mayo Clinic, Barrow Neurological
Institute, University of Arizona Health Science Center, Banner Sun Health Research
Institute, and the Southern Arizona VA Healthcare System. A multidisciplinary team, which
represents all sites, makes the diagnosis of each participant enrolled in the database. Only
those participants with all data points of interest were included in this study. Ethnic
background of the participants was as follows: 90.7% White, 8.2% Hispanic, 0.6% Native
American, 0.3% Black, and 0.3% Asian.
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The Arizona ADCC confers participant diagnosis based on several criteria a) history of
symptomology b) Clinical Dementia Rating scores (Morris, 1993) (0=Cognitively normal,
0.5=MCI and 1.0-3.0=Dementia), and number of cognitive domains falling below normative
cutoff scores (e.g. 0 for controls, 1 for MCI, > 1 for AD) (McKhann et al., 2011). Therefore,
subjects diagnosed with MCI and Alzheimer's disease will have impaired scores on
cognitive tests, but the extent of impairment is not used to guide diagnosis.
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All neuropsychological measures analyzed in this study were administered at the same
testing session in a standardized fashion to all participants, as outlined in the included
references: RAVLT including a 20 minute delay and recognition trial (Geffen, Moar,
O'Hanlon, Clarck, & Geffen, 1990; Lezak, 1995), form 4 of the BVMT-R (Benedict, 1997),
Dementia Rating Scale (DRS) (Mattis, 1988), Controlled Oral Word Association Test
(COWAT) from the Multilingual Aphasia Examination (Benton & Hamsher, 1976), the
Mini-Mental State Examination (MMSE) (Folstein, Folstein, & McHugh, 1975), and the
Vocabulary subtest from the Wechsler Adult Intelligence Scale-3rd edition (WAIS-III)
(Wechsler, 1997). Inter-site reliability of test scoring and administration has been established
and confirmed through statistical analyses.
Statistical Analyses

Author Manuscript

Analyses were carried out by grouping participants according to diagnostic group
(Cognitively healthy, MCI and AD) and sex (M/F) resulting in a total of 6 groups. Between
group analyses of the following dependent variables were carried out utilizing a multivariate
analysis of variance (MANOVA): RAVLT total number of words recalled over trials 1-5
(RAVLT total) and the number of words recalled after a long delay (RAVLT delay), BVMTR total score over trials 1-3 (BVMT-R total) and the score after a delay (BVMT-R delay),
total score on the MMSE, total score on the DRS, total raw score on the Vocabulary subtest
of the WAIS-III, and the total number of words generated over three one-minute trials on the
COWAT. Post-Hoc comparisons were carried out using the Bonferroni correction for
multiple comparisons. Statistical analyses were carried out in IBM SPSS 23 (IBM Corp.,
Armonk, New York). First we carried out an omnibus MANOVA with all groups and
dependent variables. Next we carried out MANOVAs between males and females by
diagnostic group (i.e., controls, MCI, and AD). Finally, we compared the Z-scores from the
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RAVLT and BVMT-R between the males and females within the MCI and AD groups using
independent t-tests.

Results
Demographic information and test performance by diagnostic group and sex is presented in
Table 1.
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The two-way between groups MANOVA (diagnostic group by sex) was performed on the
demographic and cognitive variables. Box's M test was statistically significant (p < .01), so
we used Pillai's trace to evaluate multivariate effects, Pillai's trace = .147, [F(20,680) =
2.703, p < 0.001]. Chi-square analyses confirmed no difference (p >0.05) in the proportion
of APOE-ε4 carriers vs. non-carriers between males and females within each diagnostic
group. Of note, the identical superscript letters next to the means in Table 1 indicate which
groups are being compared.
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Within the MCI group MANOVA revealed no differences between MCI females and MCI
males in age, education, MMSE, COWAT, DRS score, WAIS-III Vocabulary, RAVLT total
score, RAVLT delayed recall, BVMT-R total score, or BVMT-R delayed recall score
[F(10,65) = 1.425, p > 0.10]. There was also no difference in global CDR score between
sexes (p >.05). Similarly, MANOVA demonstrated no statistically significant sex differences
on these cognitive or demographic measures within the AD group [F(10,90) = 1.039, p >
0.10]. Within the AD group there was no difference in global CDR score between sexes (p
>.05). In contrast to no sex differences in the MCI and AD groups, within the healthy
controls the overall MANOVA comparing males and females was significant, [F(10,166) =
6.461, p < 0.001]. Univariate analyses demonstrated no sex differences in age, COWAT, or
WAIS-III Vocabulary. However, the healthy males had approximately one more year of
education than the females (p = 0.022). Although there were statistical differences between
healthy males and females on the MMSE (p=0.030) and DRS (p=0.046) with females
scoring slightly higher, these differences would not be considered to be clinically significant
(e.g. MMSE of 29.2 for males vs. 29.5 for females) (see Table 1). In contrast, there were
significant sex differences in performance on the memory measures, which would likely be
considered clinically significant, with the females outperforming the males on RAVLT total
score, RAVLT delayed recall, BVMT-R total score, and the BVMT-R delayed recall score
even though male controls had approximately one additional year of education than females.
Sex Differences in Episodic Memory and the Effect of Dementia
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We converted the memory scores of each subject with MCI or AD to Z-scores based on the
same sex healthy controls in this study (i.e. using our controls as normative data for our
subjects with MCI or AD). We found sex differences in the extent of memory impairment
(e.g. a negative Z-score) in the dementia groups. Specifically, the performance gap between
healthy and dementing women was consistently larger than the gap between healthy and
dementing men. This sex difference was present in both the MCI and AD groups. Results are
provided in Table 2.
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Independent t-tests indicated statistically significant differences in Z-scores from memory
tests between the male and female MCI subjects. Similarly, the differences in Z-scores
between male and female AD subjects was also statistically different. T-statistics are
presented in Table 2.

Discussion

Author Manuscript

Sex differences in RAVLT raw scores were demonstrated within the healthy control but not
MCI or AD groups. Calculating Z-scores based on healthy (i.e. non-demented) controls
illustrated that, in general, women in the MCI and AD groups had much lower memory
scores compared to the healthy control range than did male MCI or AD subjects. The greater
difference in memory function in women was not simply due to more severe illness since
women and men were equivalent for level of dementia severity as indicated by CDR,
MMSE, and DRS. Sex differences were also unlikely to be related to premorbid function or
cognitive reserve in that male and females were equivalent within diagnostic groups on
Vocabulary score from the WAIS-III, a measure of verbal intelligence, and performance on
the COWAT, a measure of verbal fluency. Thus, better memory performance in the healthy
females compared to healthy males was not related to higher verbal intellectual function or
verbal fluency. Finally, sex differences were unlikely to be due to age and APOE-ε4 status as
these were also equivalent between groups.
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In contrast to our prior study (Gale et al., 2007) here we find sex differences in healthy
controls on the BVMT-R. Previous research suggests sex differences on tasks of visuospatial
memory may be found when active rather than passive visuospatial manipulation is required
(Lewin, Wolgers, & Herlitz, 2001; Millet et al., 2009). Since the BVMT-R essentially
requires no visuospatial manipulation and the stimuli can be somewhat easily verbalized,
this may explain the female advantage in our control group. In other words, the control
females had better verbal memory than control males and may have been able to verbalize
the figures on the BVMT-R resulting in better visuospatial memory.
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While some studies have not found sex differences in the incidence or pattern of cognitive
impairment in AD (Barnes et al., 2003), others have suggested increased incidence in
women (Gao, Hendrie, Hall, & Hui, 1998; Mielke, Vemuri, & Rocca, 2014) or differences in
the level of impairment in specific cognitive domains such as language function (Ripich,
Petrill, Whitehouse, & Ziol, 1995) and memory (Chapman et al., 2011). Our findings were
based on relative (to a control group), not absolute, differences between women and men.
This finding could potentially reflect differences in the disease process between the sexes.
Furthermore, this effect was present in the early stages of illness (e.g. MCI) when memory is
typically the most salient issue.
Our findings suggest that sex differences in cognitive outcome in both MCI and AD could
reflect sex differences in the extent or course of the disease. Consistent with this possibility,
Hua et al. (2010) found faster whole brain and temporal lobe atrophic rates in women with
MCI compared to males with MCI. Skup et al. (2011) also found sex differences in patterns
of atrophy in both AD and MCI. However, not all studies have found sex differences (Bai et
al., 2009). And a recent meta-analysis evaluating the prevalence of amyloid pathology in
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persons without dementia from ages 50-90 did not find a sex difference though pathology
was associated with cognitive impairment, age, and APOE genotype (Jansen et al., 2015).
Still, there may also be sex differences in relation to modifying factors of the disease. For
example, the association between the clinical manifestation of Alzheimer's disease and the
underlying neuropathology may be more robust in women than in men (Barnes et al., 2005).
The presence of the APOE-ε4 allele has also been shown to have detrimental effects on
episodic memory in women, but not in men (Lehmann et al., 2006; Mortensen & Hogh,
2001). Damoiseaux et al. (2012) found an interaction between APOE-ε4 and sex in healthy
older adults with women but not men demonstrating significantly reduced functional
connectivity in the default mode network. In another sample they found an interaction
between APOE-ε4 and cerebrospinal measurements of tau levels with healthy women
having higher levels than APOE-ε4 males. Taken together, these findings demonstrate an
APOE-ε4 by sex interaction that may clarify dementia-related sex differences and associated
changes in both functional neural networks and contributors to the underlying
neuropathology. Similarly, Heise et al (2014) found reduced connectivity in otherwise
healthy APOE-ε4 carrier females between the hippocampus and precuneus/posterior
cingulate cortex compared to APOE-ε4 carrier males, ε3 homozygote females, and ε3
homozygote males. Finally, it may also be that the disease itself is not different between the
sexes but that premorbid differences between the sexes in regional brain function and
structure interact with the disease differently. For example, Yoshizawa et al. (2014) studied
older (not elderly) healthy adults and demonstrated sex differences in cerebral glucose
metabolism, with females demonstrating increased metabolism mainly in frontal and parietal
areas while men demonstrated increased metabolism mostly in temporal regions, and that
these differences were associated with cognitive performance even after adjustment for age,
education, and MMSE. Furthermore, sex differences in regional hippocampal morphology
have been found to be associated with the onset of puberty, which reduced hippocampal
volume in males but not females (Satterthwaite et al., 2014). Thus, perhaps sex differences
in underlying brain structures/function interact differentially with the MCI/AD disease
process.
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Limitations of this study include the cross-sectional rather than longitudinal nature of the
data. Although we did not find evidence that the women with MCI or AD had greater
disease severity than the men, and they were compared to a well-defined control cohort, it is
possible that other unknown factors could have influenced our findings. For example, since
we only included participants with all data points this could have biased who was included
in the study. Also, because this was a cross-sectional study we cannot address causation.
Secondly, we did not distinguish between potential MCI subgroups (e.g. amnestic versus
other) or APOE genotype, though there were no group differences in the proportion of
APOE-ε4 carriers, and further studies may shed light on more complex interactions between
genotype, sex and cognitive impairment. Finally, our sample, including the controls, was
mostly white and highly educated making our findings less generalizable. Still, strengths of
this study include a large sample size and control group, well-documented diagnosis, and
thorough cognitive assessment.
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We found sex differences in cognition from the healthy to early and late dementing stages.
Given the implications of this finding future researchers may want to address both the timing
and mechanism of greater cognitive decline in females through longitudinal analyses.
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COWAT is total raw score on Controlled Oral Word Association Test

Vocabulary is the total raw score from the WAIS-III Vocabulary subtest

DRS total is the total raw score on the Dementia Rating Scale

MMSE is the total raw score on the Mini Mental State Examination

CDR is the Clinical Dementia Rating global score

APOE E4 is proportion of sample with presence of an Apolipoprotein-ε4 allele

The lack of superscripts between the sexes on any measures within the MCI or AD groups indicates no statistically significant differences were found.

indicates p<.01

**

indicates p<0.05,

*

a
Identical superscript letters (e.g.) represent a significant group difference between sexes.

Note. Mean and Standard Deviation (SD) are provided for each variable.
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Demographic information and test performance by diagnosis and sex
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BVMT-R Del is the total raw score after the 25′delay on the Brief Visuospatial Memory Test-Revised

BVMT-R TOT is the total raw score over trials 1-3 on the Brief Visuospatial Memory Test-Revised

RAVLT Del is the number of words recalled after the delay on the Rey Auditory Verbal Learning Test

RAVLT TOT is the total number of words recalled over trials 1-5 on the Rey Auditory Verbal Learning Test
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4.81**

Cohen's d effect size

0.63

2.66*

t

Cohen's d effect size

t

BVMT-R Del is the total score after the 25′delay.

BVMT-R TOT is the total score over trials 1-3

RAVLT Del is the number of words recalled after the delay

RAVLT TOT is the total number of words recalled over trials 1-5

M = mean, SD = standard deviation, t = t-statistic

AD = Alzheimer's disease

MCI = mild cognitive impairment
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Z-scores (separately based on male or female healthy controls), t-statistics, and effect sizes between males and females on memory test
performance in the MCI and AD groups
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